中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01763 中国同辐

未开盘 10-02 16:08:07

13.280

+0.140

+1.07%

最高13.280	最低12.820	成交量7.00万
今开13.000	昨收13.140	日振幅3.50%
总市值42.50亿	流通市值10.62亿	总股本3.20亿
成交额91.00万	换手率0.09%	流通股本7,997万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01763","market":"HK","secType":"STK","nameCN":"中国同辐","latestPrice":13.28,"timestamp":1790928487526,"preClose":13.14,"halted":0,"volume":70000,"delay":0,"changeRate":0.010654490106544809,"floatShares":79968800,"shares":320000000,"eps":1.193499007368231,"marketStatus":"未开盘","change":0.14,"latestTime":"10-02 16:08:07","open":13,"high":13.28,"low":12.82,"amount":910040,"amplitude":0.035008,"askPrice":13.28,"askSize":600,"bidPrice":12.93,"bidSize":5000,"shortable":0,"etf":0,"ttmEps":1.1908112944075204,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791163800000},"marketStatusCode":0,"adr":0,"listingDate":1530806400000,"exchange":"SEHK","adjPreClose":13.14,"dividendRate":0.028678,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"volumeRatio":0.9743875264833135,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01763/wiki","defaultTab":"wiki","newsList":[{"id":"2672110107","title":"李洪波减持中国同辐(01763.HK)2.1万股 每股作价约13.26港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2672110107","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672110107?lang=zh_cn&edition=full","pubTime":"2026-10-02 19:55","pubTimestamp":1790942130,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156340347","title":"中国同辐（01763.HK）拟于10月21日召开临时股东会 审议核技术产业基金投资协议等四项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=1156340347","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156340347?lang=zh_cn&edition=full","pubTime":"2026-09-30 07:05","pubTimestamp":1790723128,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司9月29日发布公告称，公司董事会决定于2026年10月21日10时在北京市海淀区厂洼中街66号4层403室召开2026年第二次临时股东大会，审议四项议案。审议及批准《中核（浙江）核技术应用产业投资基金合伙协议》及其项下拟进行的交易；2026年9月29日名列股东名册的股东有权出席并投票；欲参会股东须于2026年9月21日16时30分前完成股份过户登记。代理委任表格需最迟于2026年10月20日10时前送达指定地点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125942604","title":"中国同辐（01763）提名李鹏辉出任第四届董事会执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1125942604","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125942604?lang=zh_cn&edition=full","pubTime":"2026-09-29 22:32","pubTimestamp":1790692359,"startTime":"0","endTime":"0","summary":"中国同辐9月29日公告称，公司董事会已于当日决议，拟提名现任总经理李鹏辉为第四届董事会执行董事人选，其任期自公司临时股东大会审议通过之日起至第四届董事会届满之日止，届满后可连选连任。该项任命尚待临时股东大会批准生效。公司表示，待股东批准后，李鹏辉将与公司签订服务合约，其薪酬将根据董事会薪酬与考核委员会的建议并结合其职责予以确定。中国同辐将适时向股东寄发有关临时股东大会的通函及通知。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168942337","title":"中国同辐（01763）子公司Lu-177原料药DMF获美国FDA备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1168942337","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168942337?lang=zh_cn&edition=full","pubTime":"2026-09-22 22:21","pubTimestamp":1790086876,"startTime":"0","endTime":"0","summary":"2026年9月22日，中国同辐股份有限公司（01763）发布自愿性公告称，其附属公司成都中核高通同位素股份有限公司收到美国食品药品监督管理局（FDA）确认信，先前提交的Lu-177原料药药品主文件（DMF）已通过评审并正式启用。\n公告指出，DMF号的启用意味着制剂企业在向FDA申报含Lu-177放射性药物时，可直接引用该DMF资料，无需重复提交原料药相关文件，从而简化注册流程、缩短审评周期并降低申报成本。\n公司表示，此次备案将为下游合作伙伴提供合规、便捷的Lu-177原料药来源，助力相关放射性药物的临床研究及商业化推进，并有望促进更多合作项目落地，为业务拓展带来动力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669140228","title":"中国同辐(01763)：中核高通Lu-177 DMF顺利通过美国FDA备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2669140228","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669140228?lang=zh_cn&edition=full","pubTime":"2026-09-22 22:17","pubTimestamp":1790086657,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 发布公告，近日，中国同辐附属公司成都中核高通同位素股份有限公司收到美国食品药品监督管理局确认信，此前递交的Lu-177原料药DMF档已顺利通过评审，标志着中核高通Lu-177原料药 DMF档获得FDA认可，DMF号成功启动，具备供下游制剂厂商引用的资格，是中核高通在核药关键原料领域推进国际化布局的重要一步。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国同辐(01763)：中核高通Lu-177 DMF顺利通过美国FDA备案","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163396077","title":"中国同辐(01763)延期召开临时股东会并调整2026年中期股息相关时间安排","url":"https://stock-news.laohu8.com/highlight/detail?id=1163396077","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163396077?lang=zh_cn&edition=full","pubTime":"2026-09-21 23:00","pubTimestamp":1790002843,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司9月21日公告，原定于2026年9月29日举行的临时股东大会将顺延至2026年10月21日10时举行。公司同时宣布，载有中期股息及拟订立中核(浙江)核技术应用产业投资基金合伙协议交易等资料的通函，将延期至2026年9月29日或之前寄发。受临时股东会延期影响，2026年中期股息的股份过户登记暂停期、记录日期及付息日期亦作出调整。该笔中期股息的派付时间由原定的2026年11月27日前，延至2026年12月18日前。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669161473","title":"中国同辐(01763)将于12月18日派发中期股息每股0.0994元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669161473","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669161473?lang=zh_cn&edition=full","pubTime":"2026-09-21 22:58","pubTimestamp":1790002685,"startTime":"0","endTime":"0","summary":"中国同辐(01763)发布公告，该公司将于2026年12月18日派发中期股息每股0.0994元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg39.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg39.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01763","BK4585","VIG","BK4588","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665299319","title":"中国同辐(01763.HK)完成发行5亿元科技创新公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2665299319","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665299319?lang=zh_cn&edition=full","pubTime":"2026-09-07 19:46","pubTimestamp":1788781591,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153770190","title":"中国同辐首期科创公司债成功发行 5亿元 票面利率1.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153770190","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153770190?lang=zh_cn&edition=full","pubTime":"2026-09-07 19:46","pubTimestamp":1788781566,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司9月7日在上海证券交易所完成“2026年面向专业投资者公开发行科技创新公司债券（第一期）”发行工作，实际发行规模达到上限5亿元，票面利率1.50%，全场认购倍数5.86倍。公告显示，发行人董事、监事、高级管理人员、持股比例超过5%的股东及其他关联方均未参与认购。发行人称，本期债券的投资者均符合《公司债券发行与交易管理办法》等相关规定。债券简称“26 同辐 K1”，代码为246015.SH。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129884628","title":"中国同辐（01763）首期科创债簿记时间延长至19:00","url":"https://stock-news.laohu8.com/highlight/detail?id=1129884628","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129884628?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:26","pubTimestamp":1788434793,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司9月3日在上海证券交易所发布公告称，其2026年面向专业投资者公开发行科技创新公司债券（第一期）的簿记建档结束时间，由原定的2026年9月3日18:00延长至19:00。公司与簿记管理人表示，此举系“簿记建档当日市场变化较大”所致。据此前披露，中国同辐本次面向专业投资者公开发行科技创新公司债券的注册规模不超过10亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133479351","title":"中国同辐（01763）拟公开发行5亿元科创公司债 用于补充流动资金","url":"https://stock-news.laohu8.com/highlight/detail?id=1133479351","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133479351?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:12","pubTimestamp":1788351178,"startTime":"0","endTime":"0","summary":"2026年9月2日，中国同辐股份有限公司披露《中国同辐股份有限公司2026年面向专业投资者公开发行科技创新公司债券（第一期）募集说明书》，明确本期债券的核心条款及资金用途。发行结束后，公司将申请本期债券在上海证券交易所上市流通，并计划同步申请通用质押式回购资格。本期债券的详细条款、风险因素及投资者保护机制已载明于正式募集说明书，投资者可登陆上海证券交易所网站查阅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664204819","title":"中国同辐(01763)拟发行不超过5亿元科技创新公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2664204819","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664204819?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:02","pubTimestamp":1788350561,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，中国同辐股份有限公司2026年面向专业投资者公开发行科技创新公司债券(第一期)简称为“26同辐K1”，债券代码为246015。本期债券发行规模为不超过5亿元(含5亿元)。每张面值为100元，发行价格为100元/张。本期债券票面利率询价区间为1.20%-2.20%(含上下限)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491172.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128035892","title":"中国同辐（01763）拟于9月发行不超5亿元三年期科创公司债 票面利率区间1.20%-2.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128035892","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128035892?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:01","pubTimestamp":1788350494,"startTime":"0","endTime":"0","summary":"9月2日，中国同辐股份有限公司在上海证券交易所网站披露《2026年面向专业投资者公开发行科技创新公司债券（第一期）发行公告》。本期债券为公司注册总额人民币10亿元科技创新公司债券中的第二期，计划发行总规模不超过5亿元，债券简称“26同辐K1”，债券代码“246015”。扣除发行费用后，募集资金拟全部用于补充公司流动资金。债券清偿顺序等同于公司普通债务。公司将在本期债券发行结束后尽快办理上市手续，并另行公告上市日期。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123900885","title":"中国同辐8月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1123900885","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123900885?lang=zh_cn&edition=full","pubTime":"2026-09-02 16:36","pubTimestamp":1788338213,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司于2026年9月2日发布了截至2026年8月31日的证券变动月报。报告显示，公司本月股本结构与上月相比无变化。根据公告，截至2026年8月31日，中国同辐的法定（注册）股本总额保持在人民币319,874,900元不变。其中，H股已发行并上市的普通股数量为79,968,800股，内资股数量为239,906,100股，两者较上月均无增减。本月公司未出现新的股份发行、购回、注销及库藏股变动，也无任何股份期权、权证或可换股票据的发行及变动记录。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097468","title":"中国同辐(01763)发布中期业绩 归母净利润1.59亿元 同比减少1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097468","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663097468?lang=zh_cn&edition=full","pubTime":"2026-08-29 00:33","pubTimestamp":1787934822,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布截至2026年6月30日止6个月业绩，该集团期内取得营业总收入29.94亿元人民币，同比增加4.39%;归属于母公司所有者的净利润1.59亿元，同比减少1.17%;每股基本盈利0.4971元;拟派发中期股息每股0.0994元。公告称，截至2026年6月30日止六个月，我们经营五个业务分部，包括核药、核医疗装备、辐射源及应用、辐照应用，以及其他业务。归母净利润下降主要是汇算清缴调增、其他业务结构调整及国际业务汇兑损失导致利润下降。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663092069","title":"中国同辐(01763.HK)拟出资4亿元参投核技术应用产业基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2663092069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663092069?lang=zh_cn&edition=full","pubTime":"2026-08-29 00:03","pubTimestamp":1787933021,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194098197","title":"中国同辐：拟引入合作伙伴，认缴出资总额达30亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1194098197","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194098197?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:32","pubTimestamp":1787927526,"startTime":"0","endTime":"0","summary":"中国同辐（01763.HK）宣布，拟由合作方承诺认缴的出资总额将达到人民币30亿元。这一举措标志着公司在拓宽资本渠道、深化产业布局方面迈出了重要一步。根据相关公告，各合作方提议的资本认缴金额合计为30亿元人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175392611","title":"中国同辐设立基金，投资核技术在工业、农业、医疗等多领域应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1175392611","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175392611?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:32","pubTimestamp":1787927521,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司宣布，将成立一支专项基金，聚焦核技术应用领域，投资范围覆盖工业、农业、医疗及其他相关行业。中国同辐此次设立基金，显然是对这一趋势的敏锐回应，同时也为公司在未来竞争中抢占先机奠定了基础。总体来看，中国同辐的这一资本动作，既是对当前核技术应用热潮的顺水推舟，也是其长期发展战略中的关键一环，旨在打造一个多维度的技术应用生态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114404578","title":"中国同辐董事会批准与中核集团等达成合作协议——2026年8月28日","url":"https://stock-news.laohu8.com/highlight/detail?id=1114404578","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114404578?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:25","pubTimestamp":1787927136,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司董事会已于2026年8月28日正式表决通过一项合作协议，合作对象包括中核集团及其他相关方。本月末的这项决定，标志着中国同辐在产业链协同与资源整合方面迈出新的步伐。截至发稿，中国同辐尚未就合作细节发布进一步说明，不过投资者反应积极，市场对公司后续动向保持密切关注。随着2026年下半年的推进，该协议的实际执行效果将成为观察中国同辐成长轨迹的重要窗口。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196929683","title":"中国同辐（01763）拟出资4亿元参与设立30亿元核技术应用产业投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=1196929683","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196929683?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:21","pubTimestamp":1787926919,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司（01763）8月28日公告称，其董事会已批准公司作为有限合伙人，与中国核工业集团有限公司（下称“中核集团”）及其附属公司等七方共同签署《中核（浙江）核技术应用产业投资基金合伙协议》，拟设立注册地位于浙江省嘉兴市的“中核（浙江）核技术应用产业投资基金合伙企业（有限合伙）”（下称“基金”）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-isotope.com","stockEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":-0.199},{"period":"3month","weight":-0.2437},{"period":"6month","weight":-0.3267},{"period":"1year","weight":-0.1732},{"period":"ytd","weight":-0.3333}],"compareEarnings":[{"period":"1week","weight":-0.0219},{"period":"1month","weight":-0.0529},{"period":"3month","weight":0.0266},{"period":"6month","weight":-0.0456},{"period":"1year","weight":-0.1215},{"period":"ytd","weight":-0.0647}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国同辐股份有限公司是一家主要从事放射性药品、医用和工业用放射源产品的研究、开发、制造及销售的中国公司。该公司经营五个业务分部。药品分部主要提供各种显像诊断及治疗用放射性药品、尿素呼气试验药盒及测试仪，以及体外诊断试剂及药盒。放射源产品分部主要提供医疗、工业等领域用各种放射源产品及相关技术服务。辐照分部主要提供辐照灭菌服务。放射治疗设备及相关服务分部主要生产放疗设备。其他业务分部主要提供进口放射源、医用核素、进口放射性药品等产品的贸易服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.035439},{"month":2,"riseRate":0.5,"avgChangeRate":0.038778},{"month":3,"riseRate":0.375,"avgChangeRate":-0.034565},{"month":4,"riseRate":0.5,"avgChangeRate":-0.018502},{"month":5,"riseRate":0.5,"avgChangeRate":0.007801},{"month":6,"riseRate":0.5,"avgChangeRate":0.047136},{"month":7,"riseRate":0.25,"avgChangeRate":-0.02894},{"month":8,"riseRate":0.555556,"avgChangeRate":0.036902},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.049164},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.032106},{"month":11,"riseRate":0.75,"avgChangeRate":0.064372},{"month":12,"riseRate":0.5,"avgChangeRate":0.001665}],"exchange":"SEHK","name":"中国同辐","nameEN":"CIRC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国同辐,01763,中国同辐股票,中国同辐股票老虎,中国同辐股票老虎国际,中国同辐行情,中国同辐股票行情,中国同辐股价,中国同辐股市,中国同辐股票价格,中国同辐股票交易,中国同辐股票购买,中国同辐股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}